Mylan Launches Generic Xeloda Tablets
Mylan Inc. today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Mylan...
FDA Approves Genzyme’s Cerdelga (eliglustat) Capsules
Genzyme, a Sanofi company, announced today that the U.S. Food and Drug Administration (FDA) has approved Cerdelga™ (eliglustat) capsules, the only first-line oral therapy...
Bayer Receives EU Approval For EYLEA In Diabetic Macular Edema
Bayer HealthCare announced today that EYLEA (aflibercept solution for injection into the eye) has been approved by the European Commission for the treatment of...
U.S. FDA Approves INVOKAMET For The Treatment Of Adults With Type 2 Diabetes
Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved INVOKAMET, a fixed-dose therapy combining canagliflozin and metformin hydrochloride in...
Diabetes Drug pricing Now challenges Novo Nordisk
The world's biggest insulin producer, whose previously unstoppable growth has started to flag, according to the Danish firm's chief executive. Lars Sorensen is certain...